|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Study Type: | Interventional |
|---|---|
| Study Design: | Allocation: Randomized; Endpoint Classification: Safety/Efficacy Study; Intervention Model: Parallel Assignment; Masking: Open Label; Primary Purpose: Supportive Care |
| Condition: |
Hysterectomy (MeSH nr: E04.950.300.399) |
| Interventions: |
Drug: Bupivacain Drug: Morphine Drug: Propofol Drug: Fentanyl Drug: Rocuronbromid |
Participant Flow
| Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations |
|---|
| No text entered. |
| Significant events and approaches for the overall study following participant enrollment, but prior to group assignment |
|---|
| No text entered. |
| Description | |
|---|---|
| Spinal Anesthesia | Spinal anesthesia combined with intrathecal morphine |
| General Anesthesia | General anesthesia |
| Spinal Anesthesia | General Anesthesia | |
|---|---|---|
| STARTED | 91 | 89 |
| COMPLETED | 82 | 80 |
| NOT COMPLETED | 9 | 9 |
| Protocol Violation | 4 | 8 |
| Withdrew consent | 5 | 1 |
Baseline Characteristics
| Description | |
|---|---|
| Spinal Anesthesia | Spinal anesthesia combined with intrathecal morphine |
| General Anesthesia | General anesthesia |
| Spinal Anesthesia | General Anesthesia | Total | |
|---|---|---|---|
|
Number of Participants
[units: participants] |
91 | 89 | 180 |
|
Age
[units: participants] |
|||
| <=18 years | 0 | 0 | 0 |
| Between 18 and 65 years | 91 | 89 | 180 |
| >=65 years | 0 | 0 | 0 |
|
Age
[units: years] Mean ± Standard Deviation |
45.9 ± 5.5 | 46.0 ± 6.0 | 45.9 ± 5.7 |
|
Gender
[units: participants] |
|||
| Female | 91 | 89 | 180 |
| Male | 0 | 0 | 0 |
|
Region of Enrollment
[units: participants] |
|||
| Sweden | 91 | 89 | 180 |
Outcome Measures
| 1. Primary: | Duration of Hospital Stay. [ Time Frame: Within 6 months after surgery ] |
| 2. Secondary: | Occurrence and Degree of Postoperative Symptoms. [ Time Frame: Within 6 months after the surgery ] |
| 3. Secondary: | Postoperative Consumption of Analgesics and Antiemetics. [ Time Frame: Within 6 months after surgery ] |
| 4. Secondary: | Complications and Complication Rates. [ Time Frame: Within 6 months after the surgery ] |
| 5. Secondary: | Quality of Life and QALYs (Quality Adjusted Life Years). [ Time Frame: Within 6 months after the surgery ] |
| 6. Secondary: | Sick Leave. [ Time Frame: Within 6 months after the surgery ] |
| 7. Secondary: | The Stress Coping Ability Impact on Postoperative Symptoms and Recovery. [ Time Frame: Within 6 months after the surgery ] |
| 8. Secondary: | Health-related Economy. [ Time Frame: Within 6 months after the surgery ] |
More Information
| Principal Investigators are NOT employed by the organization sponsoring the study. |
| There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. |
| Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data |
|---|
| No text entered. |
| Responsible Party: | Preben Kjolhede, University Hospital, Linkoeping |
| ClinicalTrials.gov Identifier: | NCT00527332 History of Changes |
| Other Study ID Numbers: | EudraCT nr 2006-002520-41 |
| Study First Received: | September 7, 2007 |
| Results First Received: | November 14, 2011 |
| Last Updated: | January 24, 2012 |
| Health Authority: | Sweden: Medical Products Agency |